Nascent BiotechNBIO 
$0.05-0.84%24h
-0.84%24h
Global rank33549
Market cap$5.58M
Change 7d18.49%
YTD Performance-73.83%
SP500 benchmarkUnderperform
P/E-2.35
P/S0
Revenue$0
Earnings-$2.80M
Dividend yield-
Main Sector
Healthcare
Nascent Biotech (NBIO) Cash on Hand
NBIO Cash on Hand in 2022: $172.19K
According to Nascent Biotech latest financial reports the cash on hand of NBIO is $172.19K, an increase of 82.37% to 2022. At the end of 2022 company had $94.41K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
NBIO Cash on Hand History from 2019 to 2023
-
Value:-
NBIO Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $172.19K | 82.37% |
| 2022 | $94.41K | 6479.37% |
| 2021 | $1.44K | -55.41% |
| 2020 | $3.22K | -97.55% |
| 2019 | $131.47K | - |
View the Top Cash on Hand Companies 
